Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate Cancer.
Saved in:
| Title: | Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate Cancer. |
|---|---|
| Authors: | Moradpour M; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Moradi Tuchayi A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Yadav S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Jiang F; Department of Epidemiology and Biostatistics, University of California, San Francisco, California., Burger IA; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, Switzerland.; Department of Nuclear Medicine, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Pop SG; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, Switzerland., Surasi DS; Department of Nuclear Medicine, MD Anderson Cancer Center, University of Texas, Houston, Texas., Hussein A; Department of Nuclear Medicine, MD Anderson Cancer Center, University of Texas, Houston, Texas., Arora I; Department of Nuclear Medicine, MD Anderson Cancer Center, University of Texas, Houston, Texas., Aparicio A; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., de Kouchkovsky I; Department of Medicine, Hematology and Oncology Division, University of California, San Francisco, San Francisco, California., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and., Hope TA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California; thomas.hope@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and.; Department of Radiology, San Francisco VA Medical Center, San Francisco, California. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 739-743. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.271296 |
